Medical News

RSS

Senate staff raise idea of taxing indoor tanning salons

Roll Call: "The concept of an excise tax on tanning services, which could include salon walk-ins or tanning beds and sunlamps sold for residential use, was floated in a weekend Senate staff meeting on the health bill. Officials described the idea as preliminary and not being seriously considered at this time.

8 Dec 2009

Veran Medical Technologies' SPiN Drive System receives FDA marketing clearance

Veran Medical Technologies announced today that it received clearance (K091934) from the U.S. Food and Drug Administration (FDA) to market a product for the delivery of instruments through the pulmonary tract. "Veran is excited about this clearance as it allows the company to address a huge unmet clinical need in lung cancer diagnosis and treatment," said Jerome R. Edwards, Veran president and chief executive officer.

8 Dec 2009

New report: CBO underestimates savings from health bills but economists worry savings aren't enough

"Previous analyses have underestimated the potential cost-saving effects of the House and Senate health reform bill, according to a new report co-authored by the Center for American Progress Action Fund and the Commonwealth Fund," Modern Healthcare reports.

8 Dec 2009

ADVocacy for IMmunization program receives a three-year grant from the Bill & Melinda Gates Foundation

The Agence de Médecine Préventive (AMP) has received a three-year grant from the Bill & Melinda Gates Foundation to implement a program to support immunization advocacy in West Africa.

8 Dec 2009

QuantRx Biomedical launches its new flagship POC diagnostic reader device at MEDICA 2009

QuantRx® Biomedical Corporation, a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, announced today the successful debut of its new flagship point-of-care (POC) diagnostic reader device, Q-Reader™, at MEDICA 2009 on November 18-21, 2009, in Düsseldorf, Germany.

8 Dec 2009

CombinatoRx presents encouraging results from its A2A and b2AR agonist programs for B-cell malignancies

CombinatoRx, Incorporated today announced that preclinical data from its Adenosine A2A receptor (A2A) and Beta-2 Adrenergic Receptor (b2AR) Agonist oncology programs demonstrated synergistic anti-cancer activity when combined with standard-of-care therapies in multiple myeloma and other B-cell malignancies.

8 Dec 2009

Medicare seeks to cut hospital readmissions with 'Care Transitions' project

The Associated Press reports that a "major push is underway around the country to cut rehospitalizations, in part by arming patients with simple steps to keep their recovery on track," such as getting quicker follow-up doctor visits and lessening medication confusion.

8 Dec 2009

Rib-X Pharmaceuticals, Yale University expand agreement to explore new ribosome technology

Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function.

8 Dec 2009

FDA probes excessive radiation dose cases

The Associated Press/Wall Street Journal: "Federal health regulators are investigating reports of dangerous radiation levels at two more California hospitals, following earlier unsafe medical scans at a Los Angeles facility. The Food and Drug Administration is probing the use of CT scans at Glendale Adventist Medical Center and Providence St. Joseph Medical Center in Burbank, Calif. The brain scans are used to diagnose strokes.

8 Dec 2009

Acceleron Pharma's ACE-536 stimulates red blood cell production through novel mechanism

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, presented data demonstrating that ACE-536 promotes formation of red blood cells through inhibition of members of the TGF-beta superfamily, at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

Health IT: W.Va. savings forecast; federal official foresees private-sector dominance

West Virginia could save $1.1 billion in health spending by government agencies, private insurers and consumers, if the health system would switch to electronic records and do a better job centralizing patient care, according to a new report by the West Virginia Health Care Authority, a governmental group, The Associated Press/New York Times reports.

8 Dec 2009

An unexpected ally for health reform: The restaurant industry

"While many small businesses are fighting to block passage of health care reform, restaurant owners have decided to work for something they can support," Politico reports.

8 Dec 2009

BHR Pharma files an IND for its BHR-100 intravenous progesterone infusion product

BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product.

8 Dec 2009

Hemaquest Pharmaceuticals' HQK-1001 holds promise for sickle cell disease and beta thalassemia

HemaQuest Pharmaceuticals presented data from new preclinical studies and early results from clinical trials of its lead drug candidate, HQK-1001, in sickle cell disease and beta thalassemia at the annual meeting of the American Society of Hematology in New Orleans.

8 Dec 2009

Hemodynamic Therapeutics' HTI-101 clinical study for treatment-resistant hypertension meets primary endpoint

Hemodynamic Therapeutics, Inc. (HTI), a portfolio company of Cato BioVentures, announces the successful completion of its initial Phase 2 clinical study of its lead compound ("HTI-101"), a patented low-dose small-molecule investigational therapy intended for patients with treatment-resistant hypertension.

8 Dec 2009

Brazil: The largest emerging pharmaceutical market for hepatitis C virus

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that at approximately $120 million, the hepatitis C virus drug market in Brazil is among the largest emerging pharmaceutical markets for the disease.

8 Dec 2009

Francisco Partners to acquire QuadraMed

QuadraMed® Corporation, a leading provider of healthcare information technologies and services that help turn quality care into positive financial outcomes, announced that it has entered into a definitive merger agreement to be acquired by Francisco Partners, one of the world’s largest technology-focused private equity firms.

8 Dec 2009

Three university academic groups sponsored for the MetaMiner project

GeneGo, Inc., the leading systems biology tools company, announced today that Millipore Corporation has sponsored academic groups from University of Queensland, Sheffield and USC to become members of the collaborative MetaMiner (Stem Cells) project run by GeneGo. MetaMiner is a partnership program for the reconstruction of stem cell pathways and their application in analysis of experimental data as well as knowledge mining.

8 Dec 2009

Moses Cone Health System to implement Streamline Health Solutions' enterprise technology

Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that Moses Cone Health System has selected the Company's enterprise technology to improve quality and operating efficiency by providing their physicians with one view of the patient medical record across their healthcare enterprise.

8 Dec 2009

Interim data from Geron's GRNVAC1 phase II trial for AML presented

Geron Corporation today announced the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine targeting telomerase, in patients with acute myelogenous leukemia (AML) at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.

8 Dec 2009

Medical News

Senate staff raise idea of taxing indoor tanning salons

Veran Medical Technologies' SPiN Drive System receives FDA marketing clearance

New report: CBO underestimates savings from health bills but economists worry savings aren't enough

ADVocacy for IMmunization program receives a three-year grant from the Bill & Melinda Gates Foundation

QuantRx Biomedical launches its new flagship POC diagnostic reader device at MEDICA 2009

CombinatoRx presents encouraging results from its A2A and b2AR agonist programs for B-cell malignancies

Medicare seeks to cut hospital readmissions with 'Care Transitions' project

Rib-X Pharmaceuticals, Yale University expand agreement to explore new ribosome technology

FDA probes excessive radiation dose cases

Acceleron Pharma's ACE-536 stimulates red blood cell production through novel mechanism

Health IT: W.Va. savings forecast; federal official foresees private-sector dominance

An unexpected ally for health reform: The restaurant industry

BHR Pharma files an IND for its BHR-100 intravenous progesterone infusion product

Hemaquest Pharmaceuticals' HQK-1001 holds promise for sickle cell disease and beta thalassemia

Hemodynamic Therapeutics' HTI-101 clinical study for treatment-resistant hypertension meets primary endpoint

Brazil: The largest emerging pharmaceutical market for hepatitis C virus

Francisco Partners to acquire QuadraMed

Three university academic groups sponsored for the MetaMiner project

Moses Cone Health System to implement Streamline Health Solutions' enterprise technology

Interim data from Geron's GRNVAC1 phase II trial for AML presented

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News